| Literature DB >> 33087505 |
Li Wang1,2, Hong Ma1,2, Peisen Huang1,2, Yifang Xie1,2, David Near1,2, Haofei Wang1,2, Jun Xu1,2, Yuchen Yang1,2, Yangxi Xu1,2, Tiffany Garbutt1,2, Yang Zhou1,2, Ziqing Liu1,2, Chaoying Yin1,2, Michael Bressan2,3, Joan M Taylor1,2, Jiandong Liu1,2, Li Qian4,2.
Abstract
Direct reprogramming of fibroblasts to alternative cell fates by forced expression of transcription factors offers a platform to explore fundamental molecular events governing cell fate identity. The discovery and study of induced cardiomyocytes (iCMs) not only provides alternative therapeutic strategies for heart disease but also sheds lights on basic biology underlying CM fate determination. The iCM field has primarily focused on early transcriptome and epigenome repatterning, whereas little is known about how reprogramming iCMs remodel, erase, and exit the initial fibroblast lineage to acquire final cell identity. Here, we show that autophagy-related 5 (Atg5)-dependent autophagy, an evolutionarily conserved self-digestion process, was induced and required for iCM reprogramming. Unexpectedly, the autophagic factor Beclin1 (Becn1) was found to suppress iCM induction in an autophagy-independent manner. Depletion of Becn1 resulted in improved iCM induction from both murine and human fibroblasts. In a mouse genetic model, Becn1 haploinsufficiency further enhanced reprogramming factor-mediated heart function recovery and scar size reduction after myocardial infarction. Mechanistically, loss of Becn1 up-regulated Lef1 and down-regulated Wnt inhibitors, leading to activation of the canonical Wnt/β-catenin signaling pathway. In addition, Becn1 physically interacts with other classical class III phosphatidylinositol 3-kinase (PI3K III) complex components, the knockdown of which phenocopied Becn1 depletion in cardiac reprogramming. Collectively, our study revealed an inductive role of Atg5-dependent autophagy as well as a previously unrecognized autophagy-independent inhibitory function of Becn1 in iCM reprogramming.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33087505 PMCID: PMC8188650 DOI: 10.1126/scitranslmed.aay7856
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956